Immucell Corp (NASDAQ: ICCC) reported Q4 EPS of $0.04, versus ($0.05) reported last year. Revenue for the quarter came in at $2.21 million, versus $1.56 million reported last year.

For earnings history and earnings-related data on Immucell Corp (ICCC) click here.